RxSight Inc [RXST] stock prices are up 15.01% to $16.32 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RXST shares have gain 18.69% over the last week, with a monthly amount glided 13.10%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on May 19, 2025, when Wells Fargo upgraded its rating to a Overweight but kept the price target unchanged to $25 for it. Previously, Piper Sandler started tracking the stock with Neutral rating on April 15, 2025, and set its price target to $18. On April 09, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $16 on the stock. JP Morgan downgraded its rating to a Underweight and decreased its price target to $17 on April 04, 2025. BofA Securities downgraded its rating to a Underperform and reduced its price target to $22 on April 03, 2025. Stifel downgraded its rating to Hold for this stock on December 20, 2024, and downed its price target to $40. In a note dated December 11, 2024, Wells Fargo downgraded an Equal Weight rating on this stock and revised its target price from $56 to $42.
The stock price of RxSight Inc [RXST] has been fluctuating between $12.53 and $64.50 over the past year. Currently, Wall Street analysts expect the stock to reach $70.11 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $16.32 at the most recent close of the market. An investor can expect a potential return of 329.6% based on the average RXST price forecast.
Analyzing the RXST fundamentals
The RxSight Inc [NASDAQ:RXST] reported sales of 148.31M for trailing twelve months, representing a surge of 28.41%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.17%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.1 and Total Capital is -0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that RxSight Inc [NASDAQ:RXST]’s Current Ratio is 12.68. Further, the Quick Ratio stands at 11.65, while the Cash Ratio is 1.23. Considering the valuation of this stock, the price to sales ratio is 4.47, the price to book ratio is 2.37.
Transactions by insiders
Recent insider trading involved Fountain Tamara, Director, that happened on Mar 12 ’25 when 7000.0 shares were sold. Director, TAMARA R FOUNTAIN completed a deal on Mar 12 ’25 to buy 7000.0 shares. Meanwhile, Director Maniar Shweta sold 3519.0 shares on Jan 22 ’25.
